Reviva Pharmaceuticals Holdings RVPH
OTC RVPH
$0.47 -0.03 (-6.00%)
At close: Sep 30, 2026 · 4:00 PM EDT

Reviva Pharmaceuticals Holdings (RVPH) Other Non-Current Liabilities (2021 - 2025)

Updated

Reviva Pharmaceuticals Holdings' Other Non-Current Liabilities came in at $44,506 for Q3 2025, down 42.9% from $77,884 a year earlier but up 166.7% from the prior quarter.

Analysis

Reviva Pharmaceuticals Holdings (RVPH) Other Non-Current Liabilities (2021 - 2025) Analysis & Trends

At the end of FY2024, Reviva Pharmaceuticals Holdings' Other Non-Current Liabilities was $89,010, down 89.0% from FY2023.

  • Other Non-Current Liabilities carries a four-year compound annual growth rate of -53.9% (FY2020 to FY2024).
  • Going back by year, Other Non-Current Liabilities was $806,655 in FY2023 (+42.2%), $567,439 in FY2022 and $1.96 million in FY2020.
  • The five-year range for quarterly Other Non-Current Liabilities is $16,690 (Q2 2025) to $1.04 million (Q1 2021).
  • Year-over-year, Other Non-Current Liabilities has declined for seven consecutive quarters, with an average decline of 60.5% over the last eight quarters.
  • The fastest year-over-year change in Other Non-Current Liabilities over five years came in Q2 2023 (growth of 857.9%), and the weakest in Q1 2025 (a decline of 92.1%).
  • Business Quant data shows RVPH's Other Non-Current Liabilities at $16,690 (Q2 2025), $27,816 (Q1 2025) and $89,010 (Q4 2024) in the three quarters before Q3 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 Reviva Pharmaceuticals Holdings 6.16 Mn 6.16 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2025 44,506.00
Jun 30, 2025 16,690.00
Mar 31, 2025 27,816.00
Dec 31, 2024 89,010.00
Sep 30, 2024 77,884.00
Jun 30, 2024 150,205.00
Mar 31, 2024 350,478.00
Dec 31, 2023 806,655.00
Sep 30, 2023 873,411.00
Jun 30, 2023 1.01 Mn
Mar 31, 2023 556,313.00
Dec 31, 2022 567,439.00
Sep 30, 2022 105,699.00
Jun 30, 2022 105,699.00
Mar 31, 2022 283,720.00
Dec 31, 2021 372,730.00
Sep 30, 2021 650,886.00
Jun 30, 2021 851,160.00
Mar 31, 2021 1.04 Mn
API Access

Reviva Pharmaceuticals Holdings Other Non-Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-non-current-liabilities&ticker=RVPH&period=max&api_key=YOUR_API_KEY